サマリー

The global vitamin ingredients market reached a value of US$ 3.4 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Vitamin ingredients, or vitamers, refer to various organic compounds that exhibit similar properties to naturally occurring vitamins. They are obtained from fruits, vegetables and animal-based sources and are developed to fulfill nutritional deficiencies in the body. Water-soluble and fat-soluble are the two most commonly available vitamin ingredients. The water-soluble vitamers are used for immediate absorption and providing instant nourishment to the body and fat-soluble vitamers are diffused in fats and stored in the liver for later absorption. These vitamin ingredients aid in minimizing the risks of developing cardiovascular diseases, diabetes, eye disorders, signs of aging and heat strokes. As a result, they are widely used in the manufacturing of food and beverages, animal feed and pharmaceuticals.

The increasing prevalence of chronic medical ailments related to vitamin deficiencies, along with the rising geriatric population across the globe, represents one of the key factors driving the growth of the market. Furthermore, the rising demand for functional and nutritionally-enriched food products is creating a positive outlook for the market. Vitamins are considered to be an essential component of the daily diet as they aid in overall growth, digestion and neurological functions. Vitamin ingredients are used in the medical nutrition industry for the treatment of malnutrition and deficiency-related disorders. In line with this, the manufacturing of animal feed fortified with vitamers for enhanced nourishment in meat and dairy products is also contributing to the market growth. Additionally, various product innovations, such as the development of natural and allergen-free Vitamin E, are acting as other growth-inducing factors. These vitamers are extensively used in organic and herbal haircare, skincare, cosmetics and other personal care products, which, in turn, is driving the market further toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vitamin ingredients market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, form, source and application.

Breakup by Type:

Vitamin A
Vitamin B
Vitamin C
Vitamin D
Vitamin E
Vitamin K

Breakup by Form:

Tablets and Capsules
Powder
Others

Breakup by Source:

Natural
Synthetic

Breakup by Application:

Pharmaceuticals
Foods and Beverages
Personal Care Products
Animal Feed
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Archer Daniels Midland Company, BASF SA, Bluestar Adisseo Company, Btsa Biotecnologías Aplicadas S.L., Farbest-Tallman Foods Corp., Glanbia Plc, Koninklijke DSM N.V., Lonza Group, Nestlé S.A., Pfizer Inc., Rabar Pty Ltd. and The Wright Group. Key Questions Answered in This Report:
How has the global vitamin ingredients market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global vitamin ingredients market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the form?
What is the breakup of the market based on the source?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global vitamin ingredients market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vitamin Ingredients Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Vitamin A
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Vitamin B
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Vitamin C
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Vitamin D
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Vitamin E
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Vitamin K
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Form
7.1 Tablets and Capsules
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Powder
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Source
8.1 Natural
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Synthetic
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Pharmaceuticals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Foods and Beverages
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Personal Care Products
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Animal Feed
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Archer Daniels Midland Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 BASF SA
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bluestar Adisseo Company
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Btsa Biotecnologías Aplicadas S.L.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Farbest-Tallman Foods Corp.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Glanbia Plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Koninklijke DSM N.V.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Lonza Group
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Nestlé S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Pfizer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Rabar Pty Ltd.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.13 The Wright Group
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio